The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 02, 2021

Filed:

Dec. 17, 2014
Applicant:

Fresenius Kabi Deutschland Gmbh, Bad Homburg, DE;

Inventors:

Karin Platenkamp, Enschede, NL;

Craig L. Sandford, Buffalo Grove, IL (US);

Koos Hakvoort, Emmen, NL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61J 1/14 (2006.01); A61M 1/02 (2006.01); A61J 1/10 (2006.01); C08K 5/10 (2006.01); A61J 1/20 (2006.01); A61J 1/18 (2006.01); C08K 5/11 (2006.01); C08K 5/12 (2006.01);
U.S. Cl.
CPC ...
A61J 1/1468 (2015.05); A61J 1/10 (2013.01); A61J 1/1475 (2013.01); A61J 1/18 (2013.01); A61J 1/201 (2015.05); A61J 1/2037 (2015.05); A61J 1/2048 (2015.05); A61M 1/0209 (2013.01); C08K 5/10 (2013.01); C08K 5/11 (2013.01); C08K 5/12 (2013.01); C08K 2201/014 (2013.01); C08K 2201/019 (2013.01);
Abstract

A container for blood or a blood component is provided, the container comprising one or more container walls defining an interior chamber, the container walls comprising one or more layers, the layers comprising or consisting of a composition comprising one or more polymeric materials and at least one extractable agent selected from the group consisting of a terephthalate ester, a cyclohexane dicarboxylic acid ester, a citrate ester, and a polyol ester, wherein the container further comprises one or more additional components, wherein the container comprises less than about 3% (w/w) of di-2-ethylhexyl phthalate (DEHP), preferably wherein the container comprises less than about 3% (w/w) of phthalates. Thereby, improved blood products are provided in which the DEHP or overall phthalate content is reduced.


Find Patent Forward Citations

Loading…